Overall, our findings suggest that ACP52C induces cancer‐specific apoptosis through the intricate interplay of the CP2c/YY1/MDM2 p90/p53 pathway and catastrophic DNA damage responses mediated by TDP2 squelching. Here, YY1 is linked to cancer.